Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £28.06m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Director/PDMR Shareholding

20 Jul 2020 14:00

RNS Number : 5204T
Emmerson PLC
20 July 2020
 

 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

20 July 2020

Emmerson Plc ("Emmerson" or the "Company")

 

Director/PDMR Shareholding

 

Emmerson Plc, the Moroccan focused potash development company, today announces the purchase of ordinary shares of nil par value in the capital of the Company ("Ordinary Shares") by directors and PDMRs.

 

Mr Edward McDermott, a Non-Executive Director of the Company, purchased 125,000 Ordinary Shares at 4.9 pence per share. Following this purchase, Mr McDermott holds 475,000 Ordinary Shares representing approximately 0.07% per cent of the Company's issued share capital.

 

Mr Graham Clarke, the Chief Executive Officer of the Company, purchased 500,000 Ordinary Shares at 4.94 pence per share. Following this purchase, Mr Clarke holds 500,000 Ordinary Shares representing approximately 0.07% per cent of the Company's issued share capital.

 

Mr Hayden Locke, a Director of the Company, purchased 251,509 Ordinary Shares at 4.8875 pence per share. Following this purchase, Mr Locke holds 1,726,644 Ordinary Shares representing approximately 0.26% per cent of the Company's issued share capital.

 

 

For further information, please visit www.emmersonplc.com , follow us on Twitter (@emmerson_plc), or contact:

 

Hayden Locke Emmerson Plc Tel: +44 (0) 207 236 1177

Edward McDermott

 

Damon Heath Shard Capital Partners LLP Tel: +44 (0) 7186 9007

Isabella Pierre

 

Megan Denison St Brides Partners Ltd Tel: +44 (0) 20 7236 1177

Isabel de Salis Financial PR/IR

 

The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Edward McDermott

2

 

Reason for the notification

 

a)

 

Position/status

 

Director ( Non-Excutive)

b)

 

Initial notification /Amendment

 

Intial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Emmerson PLC

b)

 

LEI

 

213800FPF38IBPRFPU87

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

EML.L

 

b)

 

Nature of the transaction

 

Share Purchase

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

4.9pence per share

125,000

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

125,000

- Price

4.9 Pence per share

e)

 

Date of the transaction

 

20 July 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Graham Clarke

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Intial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Emmerson PLC

b)

 

LEI

 

213800FPF38IBPRFPU87

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

EML.L

 

b)

 

Nature of the transaction

 

Share Purchase

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

4.94pence per share

500,000

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

500,000

- Price

4.94 Pence per share

e)

 

Date of the transaction

 

 

17 July 2020

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Hayden Locke

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

 

Intial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Emmerson PLC

b)

 

LEI

 

213800FPF38IBPRFPU87

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

EML.L

 

b)

 

Nature of the transaction

 

Share Purchase

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

4.8875pence per share

251,509

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

251,509

- Price

4.8875pence per share

e)

 

Date of the transaction

 

20 July 2020

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUPAMUPUGPU
Date   Source Headline
30th Mar 20267:00 amRNSArbitration Memorial Submission
24th Mar 20267:00 amRNSResult of WRAP Retail Offer
20th Mar 20267:31 amRNSWRAP Retail Offer for up to £100,000
20th Mar 20267:30 amRNSResult of Placing and Subscription
20th Mar 20267:00 amRNSProposed Placing and Subscription
22nd Jan 20267:00 amRNSArbitration Update
26th Nov 20257:00 amRNSAppointment of Joint Broker
30th Sep 20257:00 amRNSInterim Results
24th Jul 202512:31 pmRNSResult of Annual General Meeting
1st Jul 20257:00 amRNSNotice of AGM
30th Jun 20253:36 pmRNS2024 Financial Results
1st May 20258:10 amRNSRequest for Arbitration
17th Mar 20257:00 amRNSLitigation Funding Update
13th Jan 20253:03 pmRNSAdditional Issuance of Shares and Rights
2nd Jan 20257:00 amRNSLitigation Funding Secured
12th Dec 20247:00 amRNSAdditional Issuance of Shares and Rights
6th Dec 20247:01 amRNSFundraising of £0.85 million
1st Nov 20247:00 amRNSNotice of dispute with Moroccan Government
28th Oct 20247:00 amRNSESIA Process, Board Changes, and Cash Management
14th Oct 20247:00 amRNSESIA Update
27th Sep 20247:00 amRNSInterim Results and Q3 Update
5th Jul 20247:00 amRNSQ2 Update
1st Jul 20247:00 amRNSChange of Nominated Advisor and Joint Broker
26th Jun 202411:33 amRNSResult of Annual General Meeting
31st May 202410:56 amRNSGrant of Share Options and PDMR dealing
31st May 20247:00 amRNSNotice of AGM and Posting of Annual Report
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.